Inhibition of rat mammary tumorigenesis by human chorionic gonadotropin associated with increased expression of inhibin

Molecular Carcinogenesis

Volumn 26, Issue 1, 1999, Pages 10-19

  Srivastava, Pramod ^a   Russo, Jose ^a   Russo, Irma H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Gonadotropins; Mammary carcinogenesis; Tumor inhibition; Tumor suppressor

Indexed keywords

CHORIONIC GONADOTROPIN; INHIBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; CANCER INHIBITION; GENE ACTIVATION; HISTOPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RNA ANALYSIS; TISSUE CULTURE; TUMOR REGRESSION;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CHORIONIC GONADOTROPIN; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, FOS; GENES, JUN; GENES, MYC; HUMANS; IMMUNOHISTOCHEMISTRY; INHIBINS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; PROTO-ONCOGENE PROTEINS C-MYC; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANS-ACTIVATION (GENETICS);

ANIMALIA;

EID: 0032827144     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199909)26:1<10::AID-MC2>3.0.CO;2-S     Document Type: Article

References (45)

1. Russo J, Russo IH. Influence of differentiation and cell kinetics on the susceptibility of the mammary gland to carcinogenesis. Cancer Res 1980;40:2677-2687.
2. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994;3:353-364.
3. Russo IH, Koszalka M, Gimotty PA, Russo J. Protective effect of chorionic gonadotropin on DMBA-induced mammary carcinogenesis. Br J Cancer 1990;62:243-247.
4. Russo IH, Koszalka M, Russo J. Human chorionic gonadotropin and rat mammary cancer prevention. J Natl Cancer Inst 1990;82:1286-1289.
5. Russo IH, Russo J. Chorionic gonadotropin: A tumoristatic and preventive agent in breast cancer. In: Teicher BA, editor. Drug resistance in oncology. New York: Marcel Dekker Inc: 1992. p 537-560.
6. Russo IH, Koszalka M, Russo J. Effect of human chorionic gonadotropin on mammary gland differentiation and carcinogenesis. Carcinogenesis 1990;11:1849-1855.
7. Grubbs CJ, Juliana MM, Hill DL. Suppression by pregnancy of chemically induced preneoplastic cells of rat mammary gland. Anticancer Res 1986;6:1395-1400.
8. Sinha DK, Pazik JE. Tumorigenesis of mammary gland by 7,12-dimethylbenz[a]anthracene during pregnancy: Relationship with DNA synthesis, Int J Cancer 1981;27: 807-810.
9. Simpson ER, MacDonnald PC. Endocrine physiology of the placenta. Annu Rev Physiol 1981;43:163-188.
10. Russo J, Tay LK, Russo IH. Differentiation of the mammary gland and susceptibility to carcinogenesis. Breast Cancer Res Treat 1982;2:5-73.
11. Russo IH, Russo J. Mammary gland neoplasia in long term rodent studies. Environ Health Perspect 1996;104: 938-967.
12. Russo IH, Russo J. Role of hCG and inhibin in breast cancer. Int J Oncol 1994;4:297-306.
13. Alvarado MV, Ho T-Y, Russo J, Russo IH. Human chorionic gonadotropin regulates the synthesis of inhibin in the ovary and mammary gland of rat. Endocrine 1994;2: 1107-1114.
14. Alvarado MV, Alvarado NE, Russo J, Russo IH. Human chorionic gonadotropin inhibits proliferation and induces expression of inhibin in human 7reast epithelial cells. In Vitro 1994;30A:4-8.
15. Alvarado MV, Russo J, Russo IH. Immunolocalization of inhibin in the mammary gland of rats treated with human chorionic gonadotropin (hCG). J Histochem Cytochem 1993;41:29-34.
16. Matzuk MM, Finegold MJ, Su J-G, Hsueh AJW, Bradley E. Inhibin is a tumor-suppressor gene with gonadal specificity in mice. Nature 1992;360:313-319.
17. Srivastava P, Russo J, Russo IH. Chorionic gonadotropin inhibits rat mammary carcinogenesis through activation of programmed cell death. Carcinogenesis 1997;18: 1799-1808.
18. De Jong FH. Inhibin. Physiol Rev 1988;68:555-607.
19. De Jong FH, Sharpe RM. Evidence for inhibin-like activity in bovine follicular fluid. Nature 1976;263:71-72.
20. Vale W, Hsueh A, Rivier C, Yu J. The inhibin/activin family of hormones and growth factors. Handbook of Experimental Pharmacology 1990;95:211-248.
21. Robertson DM. Transforming growth factor-β/inhibin family. Baillieres Clin Endocrinol Metab 1991;5:615-634.
22. Woodruff TK, Mayo K. Regulation of inhibin synthesis in the rat ovary. Annu Rev Physiol 1990;52:807-821.
23. Ransone LJ, Verman IM. Nuclear proto-oncogenes fos and jun. Annual Review of Cell Biology 1990;6:539-557.
24. Curran T, Morgan JI. Memories of fos. BioEssays 1990;7: 255-258.
25. Lau LF, Nathan D. Expression of a set of growth-related immediate early genes in Balb/c 3T3 cells. Coordinate regulation with c-fos and c-myc. Proc Natl Acad Sci USA 1987;84:1182-1186.
26. Russo J, Russo IH, van Zwieten MJ, Rogers AE, Gusterson B. Classification of neoplastic and non-neoplastic lesions of the rat mammary gland. In: Jones TC, Mohr U, Hunt RD, editors. Integument and mammary glands of laboratory animals. Berlin: Springer Verlag; 1989. p 275-304.
27. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
28. Tahin Q, Mgbonyebi OP, Russo J, Russo IH. Influence of hormonal change induced by the placental hormone chorionic gonadotropin on the progression of mammary tumorigenesis Abstract. Proceedings of the American Association for Cancer Research 1996;37:1622.
29. Russo J, Russo IH. Human chorionic gonadotropin in breast cancer prevention. In: Ethier S, editor. Endocrine oncology. Totowa, NJ: Humana Press Inc., in press.
30. Nandi S, Guzman RC, Yand J. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis. Proc Natl Acad Sci USA 1995;92:3650-3657.
31. Petraglia F, Sawchenko P, Lim ATW, Rivier J, Vale W. Localization, secretion, and action of inhibin in human placenta. Science 1987;237:187-192.
32. Petraglia F, Garuti GC, Calza L, et al. Inhibin subunits in human placenta: Localization and messenger ribonucleic acid levels during pregnancy. Am J Obst Gynecol 1991; 165:750-758.
33. Meunier H, Rivier C, Evans R, Vale W. Gonadal and extragonadal expression of inhibin A and B subunits in various tissues predicts diverse functions. Proc Natl Acad Sci USA 1988;85:247-251.
34. Haji M, Nishi Y, Tanaka S, et al. Evidence for the secretion of inhibin-like immunoreactivity from cultured human adrenal cells. J Endocrinol 1991;128:13-16.
35. Blauer M, Kohonen J, Leivonen I, Vilja P, Touhimaa P. Inhibin alpha and beta A subunit immunoreactivity in the chicken embryo during morphogenesis. Development 1992;115: 1079-1086.
36. Kyprianou N, English HF, Davidson NE, Issacs JT. Programmed cell death during regression of MCF7 human breast cancer following estrogen ablation. Cancer Res 1991;51:162-166.
37. Miller Jr WH, Dmitrovsky E. Retinoic acid audits rearranged receptor in the treatment of acute promyelocytic leukemia. In: De Vita V, Hellman S, Rosenberg, SA, editors. Important advances in oncology. Philadelphia: J. B. Lippincott Co; 1993. p 81-90.
38. Iwai SA, Kosaka M, Nishinu Y, Sumi T, Sakuda M, Nishimune Y. Changes in Hox 1.6, c-jun and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction. Exp Cell Res 1993;205: 39-43.
39. Draetta G. Cell cycle control in eukaryotes. Trends Biochem Sci 1990;15:378-383.
40. Evan GI, Littlewood TD. The role of c-myc in cell growth. Current Opin Genet Dev 1993;3:44-49.
41. Hunzicker-Dunn M, Birnbauer L. The involvement of adenylyl cyclase and cyclic AMP-dependent protein kinases in luteinizing hormone action. In: Ascoli M, editor. Luteinizing hormone action and receptors. Boca Raton, FL: CRC Press, Inc; 1985. p 57-134.
42. Wang Z, Liu X, Ascoli M. Phosphorylation of the lutropin/ choriogonadotropin receptor facilitates uncoupling of the receptor from adenylyl cyclase and endocytosis of the bound hormone. Mol Endocrinol 1997;11:183-192.
43. Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Anticancer Res 1998;178:4003-4010.
44. Meduri G, Charnaux N, Loosfelt H, Jolivet A, Spyratos F, Brailly S, Milgrom E. Luteinizing hormone/human chorionic gonadotropin receptors in breast cancer. Cancer Res 1997; 57:857-864.
45. Lojun S, Bao S, Lei ZM, Rao CV. Presence of functional luteinizing hormone/chorionic gonadotropin (hCG) receptors in human breast cell lines: Implications supporting the premise that hCG protects women against breast cancer. Biol Reprod 1997;57:1202-1210.